Clinical trial · Interventional
The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy
NCT04837742CI-TRIAL-00066723completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a double blind, randomized controlled trial to evaluate the efficacy of ESPB(Erector Spinae Plane Block) on postoperative analgesia in RFA( Radiofrequency Ablation therapy). We will include 80 patients, and randomly assign to ESPB(Chirocaine) group and control group(normal saline).We deduce Erector spinae plane block can be use as a postoperative analgesic way for patients who receive radiofrequency ablation of hepatocellular carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control group | Drug | — | UNRESOLVED |
| ESPB group | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ESPB group
- description
- ESPB injection at T10 region with levobupivacaine 100mg (20 ml)+ Omnipaque10 ml
- interventionNames
- Drug: ESPB group
- type
- SHAM_COMPARATOR
- label
- Control group
- description
- ESPB injection at T10 region with 0.9% normal saline 20ml + Omnipaque10ml
- interventionNames
- Drug: Control group
Primary outcomes (2)
- measure
- Visual analogue pain scale at postoperative day one
- timeFrame
- approximately 12-24 hrs
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Patients undergoing computed tomography guided radiofrequency ablation of hepatic tumor under scheduled general anesthesia, and fulfilled one of following inclusion criteria: 1. diameter of hepatic tumor is larger than 2 cm 2. distance of tumor site is near the hepatic surface \< 2cm Exclusion criteria: 1. A history of allergic reaction to local anesthetics or iohexol 2. Renal insufficiency, creatinine clearance \< 30mL/min 3. Coagulopathy or other bleeding disorder that cannot perform nerve block 4. Under pregnancy or lactation 5. Opioid tolerant patient
References
Publications (0)
Data not yet available
No reference posted for this study.